Search Within

Heather Jolie Landau

Formats
  1. Meeting Abstract (281)
  2. Journal Article (124)
  3. Research Letter (15)
  4. Book Section (5)
  5. Review (3)
  6. Conference Paper (1)
  7. Correspondence (1)
  8. Editorial (1)
  9. Guidelines (1)
Groups
  1. Bone Marrow Transplant (432)
  2. Center for Hematologic Malignancies (432)
  3. Department of Medicine (432)
  4. Hematologic Malignancies, Division of (432)
  5. Survivorship Research (432)
  6. Myeloma (246)

More Groups

People
  1. Sergio Giralt (260)
  2. Hani Hassoun (221)
  3. David Chung (206)
  4. Alexander Lesokhin (184)
  5. Gunjan Shah (161)
  6. Sham Mailankody (144)

More People

Years
  1. 2025 (10)
  2. 2024 (51)
  3. 2023 (48)
  4. 2022 (42)
  5. 2021 (25)
  6. 2020 (34)

More Years

Publications
  1. Blood (153)
  2. Clinical Lymphoma, Myeloma and Leukemia (53)
  3. Biology of Blood and Marrow Transplantation (48)
  4. Journal of Clinical Oncology (24)
  5. Bone Marrow Transplantation (12)
  6. Leukemia and Lymphoma (12)

More Publications

Publishers
  1. American Society of Hematology (164)
  2. Elsevier Inc. (110)
  3. Nature Publishing Group (29)
  4. American Society of Clinical Oncology (25)
  5. Taylor & Francis Group (21)
  6. Ferrata Storti Foundation (8)

More Publishers

Results (432)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis
    Journal Article

    Landau, H.; Smith, M.; Landry, C.; Chou, J. F.; Devlin, S. M.; Hassoun, H.; Bello, C.; Giralt, S.; Comenzo, R. L.
    Leukemia (2017)

    Fulltext@MSK | Save
  • The PRONTO amyloidosis study: A randomized, double-blind, placebo-controlled, global, phase 2b study of NEOD001 in previously treated subjects with light chain amyloidosis and persistent cardiac dysfunction
    Meeting Abstract

    Merlini, G.; Liedtke, M.; Landau, H. J.; Comenzo, R. L.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Schonland, S.; Guthrie, S. D.; Walling, J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Organ biomarker responses in patients with light chain amyloidosis treated with NEOD001 are independent of previous hematologic response
    Meeting Abstract

    Liedtke, M.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G. G.; Koller, M.; Schenk, D. B.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • NEOD001 demonstrates organ biomarker responses in patients with light chain amyloidosis and persistent organ dysfunction: Results from the expansion cohort of a phase 1/2 study
    Meeting Abstract

    Gertz, M. A.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G. G.; Koller, M.; Schenk, D. B.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Safety and efficacy of carfilzomib (CFZ) in previously-treated systemic light-chain (AL) amyloidosis
    Meeting Abstract

    Cohen, A. D.; Landau, H.; Scott, E. C.; Liedtke, M.; Kaufman, J. L.; Rosenzweig, M.; Gasparetto, C.; Vesole, D. H.; Sanchorawala, V.; Lentzsch, S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The VITAL amyloidosis study: A randomized, double-blind, placebo-controlled, global, phase 3 study of NEOD001 in patients with AL amyloidosis and cardiac dysfunction
    Meeting Abstract

    Liedtke, M.; Merlini, G.; Landau, H.; Comenzo, R. L.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G. G.; Koller, M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Final results of a phase 2 study of bendamustine in combination with dexamethasone in patients with previously treated systemic light-chain (AL) amyloidosis
    Meeting Abstract

    Lagos, G. G.; Lentzsch, S.; Comenzo, R. L.; Zonder, J.; Osman, K.; Gould, J.; Tsai, W. Y.; Pregja, S.; Reyna, M.; Raza, S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Whole exome sequencing from nine independent sites of extraosseous disease in a single patient with relapsed multiple myeloma show that extramedullary disease arise through a combination of branched and parallel evolution
    Meeting Abstract

    Landau, H.; Fan, J.; Giralt, S. A.; Peled, J. U.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; Korde, N. S.; Mailankody, S.; Chung, D. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy
    Meeting Abstract

    Hassoun, H.; Roshal, M.; Sabari, J.; Cooper, B.; Nguyen, J.; Ruiz, R.; Gao, Q.; Landau, H.; Lendvai, N.; Chung, D. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Comparison of standard assays (serum immunofixation and protein electrophoresis) with Hevylite assay in patients with multiple myeloma
    Meeting Abstract

    Hassoun, H.; Ruiz, R.; Kazunori, M.; Azzi, K.; Devlin, S.; Cooper, B.; Lendvai, N.; Landau, H.; Lesokhin, A. M.; Chung, D. J.; more...
    Blood (2016)

    Fulltext@MSK | Save